Trials / Completed
CompletedNCT03778320
A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers
A Randomized Single Dose Crossover Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of CTP-692 Versus D-Serine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Concert Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the safety, tolerability and pharmacokinetic (PK) profile of CTP-692 vs D serine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTP-692 | Single oral dose |
| DRUG | D-Serine | Single oral dose |
Timeline
- Start date
- 2018-12-14
- Primary completion
- 2018-12-23
- Completion
- 2019-01-31
- First posted
- 2018-12-19
- Last updated
- 2019-03-15
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03778320. Inclusion in this directory is not an endorsement.